Alzheimer's Prevention Initiative in the News
The Banner Alzheimer's Institute is collaborating on the first-ever study of an experimental drug that is hoped to stop Alzheimer's before it starts.
The study, a partnership between BAI, Genentech and National Institutes of Health and other research leaders, is the cornerstone of a new international collaborative, the Alzheimer’s Prevention Initiative (API).
|
|
The study will involve about 300 participants from Colombian families who share a rare genetic mutation that typically triggers Alzheimer’s symptoms around age 45. The study will also include a small number of individuals in the United States.
In the news:
- New drug trial aims to prevent Alzheimer's before it starts
Time (May 17, 2012) - Banner tests experimental drugs to halt Alzheimer's
The Arizona Republic (May 15, 2012) - Testing a drug that may stop Alzheimer's before it starts
The New York Times (May 15, 2012) - Alzhiemer's prevention? New drug trial brings promise
CBS This Morning (May 16, 2012) - Alzheimer's Prevention drug trial
KAET (May 16, 2012) - Study to test antibody crenezumab for preventing Alzheimer's
USA Today (May 15, 2012) - Roche's Alzheimer drug picked for major test
Fox News (May 16, 2012) - Banner Alzheimer's Institute launching $100 million clinical trial
The Phoenix Business Journal (May 15, 2012) - Alzheimer's trial targets early prevention
Wall Street Journal (May 15, 2012) - Research to prevent Alzheimers will target group with rare form
ABC News (May 15, 2012) - Roche drug picked for major Alzheimer's test
Reuters (May 15, 2012) - Genetech to test Alzheimer's drug on healthy patients in historic first prevention trial
Reuters (May 15, 2012) - Alzheimer's research efforts seek new treatments by 2025
Bloomberg (May 15, 2012) - Promising new Alzheimer's drug to meet its first test
San Francisco Chronicle (May 15, 2012)
